Aubra Eq
Product Images NDC 53002-2692

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aubra Eq (NDC 53002-2692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022692)

FDA Label Image

Figure I: Mean (se) Levonorgestrel And Ethinyl Estradiol Serum Concentrations In 22 Subjects Receiving Levonorgestrel And Ethinyl Estradiol (100 Mcg Levonorgestrel And 20 Mcg Ethinyl Estradiol) (Levo Ethi Fig1)

FDA Label Image

Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral-contraceptive Use (Levo Ethi Fig2)

FDA Label Image

Levo-ethi-fig3 (Levo Ethi Fig3)

FDA Label Image

Levo-ethi-fig4 (Levo Ethi Fig4)

FDA Label Image

Levo-ethi-fig5 (Levo Ethi Fig5)

FDA Label Image

Levo-ethi-fig6 (Levo Ethi Fig6)

FDA Label Image

Levo-ethi-fig7 (Levo Ethi Fig7)

FDA Label Image

Chemical Structure (Levo Ethi Str)

Ethinyl Estradiol is a synthetic form of the hormone estradiol, which is a type of estrogen. It is commonly used as an ingredient in hormonal contraceptives, such as birth control pills. Ethinyl Estradiol works by preventing ovulation and altering the cervical mucus to make it more difficult for sperm to reach the uterus. It is also used in hormone replacement therapy for menopausal women. This medication may have various side effects, including nausea, breast tenderness, and changes in menstrual bleeding. It should only be used under the guidance of a healthcare professional.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.